Alexion Pharmaceuticals (ALXN) PT Raised to $149 at Wedbush
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Alexion Pharmaceuticals (ALXN) PT Lowered to $150 at Oppenheimer
October 24, 2019 9:25 AM EDTOppenheimer analyst Hartaj Singh lowered the price target on Alexion Pharmaceuticals (NASDAQ: ALXN) to $150.00 (from $165.00) while maintaining a Outperform rating.
The analyst commented, "Alexion (ALXN) reported 3Q19 sales/earnings and provided an investor update on 10/23. The company upgraded its financial guidance for... More
